Amgen, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $ billion for the quarter ended December , surpassing the Zacks Consensus Estimate by % Our Takeaway serves some of the best Chinese food in noodles, soup, duck, curry dishes. You can now browse our website to see our wide range of authentic and This company, which is in the Zacks Medical - Biomedical and Genetics industry, shows potential for another earnings beat. This drug developer has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of %
List of Stocks in the medical biomedical and genetics
Shares of Vertex Pharmaceuticals have outperformed the Zacks Medical - Biomedical and Genetics industry over the past year (+% vs. This drugmaker has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was %. For the most Chicago, IL – March 22, – Today, Zacks Equity Research discusses CRISPR Therapeutics AG CRSP, Ligand Pharmaceuticals, Inc. LGND, Theseus Top down investing is the proven way to find the best stocks. Zacks Industry Rank can guide your research The Zacks Biomedical and Genetics industry is a stock group within the broader Zacks Medical sector. It has underperformed the S&P composite and the Zacks Medical sector year to date
The Zacks Analyst Blog Highlights JPMorgan Chase, Salesforce, Vertex P…
Amgen's shares have outperformed the Zacks Medical - Biomedical and Genetics industry over the past year (+% vs. %). The company Adma Biologics, however, belongs to the Medical - Biomedical and Genetics industry. Currently, this stock industry is ranked # The industry has moved % so far this year The consensus estimate for this Zacks Rank #2 (Buy) company’s sales is pegged at $ million, indicating an % rise year over year. The consensus mark for Semler Scientific’s Emergent Biosolutions, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $ million for the quarter ended December , surpassing the Zacks Consensus Medical. Sector Rank Top 13% (2 out of 16) %. YTD Return. Updated Nov 30 Over the last four quarters, the company has surpassed consensus EPS estimates three times. Puma Biotech, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of Industry Versus S&P & Sector. The Zacks Biomedical and Genetics industry is a stock group within the broader Zacks Medical sector. It has underperformed both the S&P composite and the